Unihealth Hospitals files FY27 H1 presentation, income ₹77.78 crore
Key highlights
- Unihealth Hospitals filed its H1 FY27 investor presentation on November 21, 2026, reporting total income of ₹77.78 crore.
- Revenue from operations rose 14.7% year-on-year to ₹76.45 crore in H1 FY27.
- EBITDA was ₹25.91 crore, with an EBITDA margin of 33.31%.
- Unihealth Hospitals scheduled its H1 FY27 earnings call for November 25, 2026, at 4 PM IST.
powered by IRIS

Unihealth Hospitals Limited filed its H1 FY27 investor presentation on November 21, 2026, reporting total income of ₹77.78 crore for the half year ended September 30, 2026. The presentation also showed revenue from operations of ₹76.45 crore, up 14.7% year-on-year, and confirmed an earnings conference call for November 25.
Know Unihealth Hospitals inside out
Results, valuation, peers and who's buying, in one view.
What did Unihealth Hospitals disclose in its H1 FY27 presentation?
Unihealth Hospitals disclosed H1 FY27 total income of ₹77.78 crore, EBITDA of ₹25.91 crore and profit attributable to owners of ₹14.22 crore. The filing covers the April-September 2026 period and presents the company’s financial and operating position while it expands hospital capacity in India and Uganda.
Revenue from operations rose from ₹66.67 crore in H1 FY26 to ₹76.45 crore in H1 FY27. The company described this as growth of 14.7% year-on-year. Total income was modestly higher than revenue from operations, reflecting other income reported during the period.
The presentation also set out an earnings conference call at 4 PM IST on November 25, 2026. Investors will have an opportunity to seek further details on the reported numbers, hospital ramp-up and capacity plans during that call.
How did profitability and cash flow change during the half year?
Unihealth Hospitals reported an EBITDA margin of 33.31% in H1 FY27, compared with 49.77% in the corresponding previous-year period. EBITDA was ₹25.91 crore, while profit attributable to owners was ₹14.22 crore, 5.9% lower than ₹15.11 crore a year earlier.
The company attributed the cost pressure to the ramp-up of new hospitals and higher finance costs. Operating expenditure increased 48.5% year-on-year, while finance costs rose 56%, according to the presentation. These factors affected profitability even as revenue increased.
Cash generation from operations was positive at ₹23.83 crore, equivalent to about 92% of EBITDA. This was above the ₹5.69 crore of operating cash flow reported for the whole of FY26, according to the disclosed comparison. The cash flow figure is relevant because the company is simultaneously funding a substantial expansion programme.
Got a follow-up? Ask IRIS
What hospital expansion steps were included in the filing?
Unihealth Hospitals said it incurred capital expenditure of about ₹74.87 crore during H1 FY27 for property, plant and equipment supporting expansion in India and Uganda. Its owned and managed network had reached 400 operational beds across four hospitals after patient services commenced at the 200-bed Nashik facility.
The presentation also recorded the acquisition of an additional 49.81% stake in Victoria Hospital Limited in Uganda through a share swap completed on September 2, 2026. This raised Unihealth Hospitals’ total ownership in Victoria Hospital Limited to 99.81%.
Management outlined a longer-term objective of commissioning more than 1,000 beds across India and Africa. It also referred to a proposed 125-150-bed hospital in Pune by the end of FY27, subject to finalisation of the location and ownership structure. The filing did not provide quantified revenue-growth guidance.
Why does the H1 FY27 presentation matter for investors?
The presentation matters because it shows the balance between Unihealth Hospitals’ revenue growth, operating cash generation and the cost of building new hospital capacity. Revenue increased 14.7% year-on-year, but the EBITDA margin declined as newly commissioned facilities and related operating costs were absorbed.
For investors, the disclosed ₹74.87 crore capital expenditure is a significant operational data point. It indicates that a large part of the company’s current activity is directed toward expanding infrastructure rather than only optimising earnings from existing facilities. The positive operating cash flow of ₹23.83 crore provides a separate measure of cash generated by operations during this investment phase.
The increase in the Victoria Hospital Limited stake also changes the ownership profile of a key Ugandan business. With 99.81% ownership, Unihealth Hospitals has near-complete control of that hospital entity. The filing does not quantify the future financial contribution expected from the higher ownership or from the newer facilities.
Conclusion
Unihealth Hospitals’ November 21 filing provides a consolidated view of H1 FY27 performance, with ₹77.78 crore in total income, ₹76.45 crore in revenue from operations and ₹23.83 crore in operating cash flow. It also records lower owner-attributable profit and EBITDA margin amid higher operating and finance costs linked to expansion.
The next disclosed event is the earnings conference call scheduled for November 25, 2026, at 4 PM IST. Investors may watch for further discussion on Nashik’s ramp-up, the Pune hospital proposal, Victoria Hospital Limited integration and the path toward the company’s stated goal of more than 1,000 commissioned beds.


